Details

Autor(en) / Beteiligte

• Rózga, Małgorzata
• Bittner, Tobias
• Batrla, Richard
• Karl, Johann
• Zetterberg, Henrik

Titel

Preanalytical sample handling recommendations for Alzheimer's disease plasma biomarkers

Ist Teil von

• Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2019-12, Vol.11 (1), p.291-300

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2019

Quelle

Wiley Online Library

Beschreibungen/Notizen

• We examined the influence of common preanalytical factors on the measurement of Alzheimer's disease–specific biomarkers in human plasma. Amyloid β peptides (Aβ[1-40], Aβ[1-42]) and total Tau plasma concentrations were quantified using fully automated Roche Elecsys assays. Aβ(1-40), Aβ(1-42), and total Tau plasma concentrations were not affected by up to three freeze/thaw cycles, up to five tube transfers, the collection tube material, or the size; circadian rhythm had a minor effect. All three biomarkers were influenced by the anticoagulant used, particularly total Tau. Aβ concentrations began decreasing 1 hour after blood draw/before centrifugation and decreased by up to 5% and 10% at 2 and 6 hours, respectively. For separated plasma, time to measurement influenced Aβ levels by up to 7% after 6 hours and 10% after 24 hours. Our findings provide guidance for standardizing blood sample collection, handling, and storage to ensure reliable analysis of Alzheimer's disease plasma biomarkers in routine practice and clinical trials. •Blood-based Alzheimer's disease biomarkers were measured with fully automated and highly precise Roche Elecsys assays.•Preanalytical sample handling affected measured concentrations of biomarkers.•Time between sample collection and centrifugation, and between centrifugation and measurement, impacted the measured concentrations of Aβ peptides.•Type of anticoagulant substantially affected measured levels of total Tau.•Recommendations for standardized sample collection and processing are provided.